Senescence‐Targeted and NAD + ‐Dependent SIRT1‐Activated Nanoplatform to Counteract Stem Cell Senescence for Promoting Aged Bone Regeneration
Small · 2024
DOI: 10.1002/smll.202304433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Ying Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Ultrafine Materials of Ministry of Education, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Engineering Resea…. Hauptthemen laut MEDLINE: Sirtuin 1, NAD. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Frontiers Science Center for Materiobiology and Dynamic Chemistry, National Natural Science Foundation of China, Basic Science Center Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
Age‐related bone defects are a leading cause of disability and mortality in elderly individuals, and targeted therapy to delay the senescence of bone marrow‐derived mesenchymal stem cells (MSCs) has emerged as a promising strategy to rejuvenate bone regeneration in aged scenarios. More specifically, activating the nicotinamide adenine dinucleotide (NAD + )‐dependent sirtuin 1 (SIRT1) pathway is demonstrated to effectively counteract MSC senescence and thus promote osteogenesis. Herein, based on an inventively identified senescent MSC‐specific surface marker Kremen1, a senescence‐targeted and NAD + dependent SIRT1 activated nanoplatform is fabricated with a dual delivery of resveratrol (RSV) (SIRT1 promoter) and nicotinamide riboside (NR, NAD + precursor). This targeting nanoplatform exhibits a strong affinity for senescent MSCs through conjugation with anti‐Kremen1 antibodies and enables specifically responsive release of NR and RSV in lysosomes via senescence‐associated β‐galactosidase‐stimulated enzymatic hydrolysis of the hydrophilic chain. Furthermore, this nanoplatform performs well in promoting aged bone formation both in vitro and in vivo by boosting NAD + , activating SIRT1, and delaying MSC senescence. For the first time, a novel senescent MSC‐specific surface marker is identified and aged bone repair is rejuvenated by delaying senescence of MSCs using an active targeting platform. This discovery opens up new insights for nanotherapeutics aimed at age‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Ultrafine Materials of Ministry of Education, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Engineering Research Center for Biomaterials of Ministry of Education, School of Materi…
- Department of Orthopedics, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200080, P. R. China.
Förderung
- Frontiers Science Center for Materiobiology and Dynamic Chemistry
- National Natural Science Foundation of China
- Basic Science Center Project of National Natural Science Foundation of China
- National Key R&D Plan Project
- 2022Outstanding Technical Leader in Shanghai
Zitieren
APA
Wang, Y., Xie, F., He, Z., Che, L., Chen, X., Yuan, Y., & Liu, C. (2024). Senescence‐Targeted and NAD + ‐Dependent SIRT1‐Activated Nanoplatform to Counteract Stem Cell Senescence for Promoting Aged Bone Regeneration. Small. https://doi.org/10.1002/smll.202304433
Vancouver
Wang Y, Xie F, He Z, Che L, Chen X, Yuan Y, et al. Senescence‐Targeted and NAD + ‐Dependent SIRT1‐Activated Nanoplatform to Counteract Stem Cell Senescence for Promoting Aged Bone Regeneration. Small. 2024. doi:10.1002/smll.202304433
BibTeX
@article{Wang2024,
author = {Wang, Ying and Xie, Fangru and He, Zirui and Che, Lingbin and Chen, Xi and Yuan, Yuan and Liu, Changsheng},
title = {Senescence‐Targeted and NAD + ‐Dependent SIRT1‐Activated Nanoplatform to Counteract Stem Cell Senescence for Promoting Aged Bone Regeneration},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202304433}
}
EUVIMED